Bed Bath & Beyond, Levi Strauss, Walgreens and More Earnings Coming This Week

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Bed Bath & Beyond, Levi Strauss, Walgreens and More Earnings Coming This Week

© Thinkstock

Here, 24/7 Wall St. offers a preview of what to expect from some of the most anticipated quarterly results due this week. We have included the consensus earnings estimates from Thomson Reuters and the stock price and trading history.

Be advised that the earnings and revenue estimates may change ahead of the formal reports, and some companies may change earnings dates as well.

Paychex Inc. (NASDAQ: PAYX | PAYX Price Prediction) is expected to post results for its most recent quarter on Tuesday morning. Analysts anticipate $0.60 in earnings per share (EPS) and $910.91 million in revenue for the fiscal fourth quarter. Shares rose above $77 apiece late last week. The consensus price target is just $69.64, and the stock has a 52-week trading range of $47.87 to $90.54.

Levi Strauss & Co. (NYSE: LEVI) will report its fiscal second-quarter results after the closing bell on Tuesday. Analysts are looking for a net loss of $0.45 per share and $574.13 million in revenue. Shares dropped below $14 on Friday. The consensus price target is $17.22, and the stock has a 52-week trading range of $9.09 to $23.74.

[nativounit]

Look for Bed Bath & Beyond Inc. (NASDAQ: BBBY) to share its fiscal first-quarter results Wednesday afternoon. Analysts expect to see a per-share net loss of $1.21 and $1.35 billion in revenue. Shares met resistance at $11 for much of last week. The consensus price target is down at $7.58, and the stock has a 52-week trading range of $3.43 to $17.79.

And Walgreens Boots Alliance Inc.’s (NASDAQ: WBA) most recent quarterly report is scheduled for Thursday morning. The consensus forecast for the fiscal third quarter calls for earnings of $1.19 a share on $34.29 billion in revenue. Shares have traded mostly around $42 apiece since mid-June, in a 52-week range of $36.65 to $64.50. The consensus analyst target is $45.82.

[recirclink id=716538][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618